Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study

Table 2 Baseline characteristics of patients

Parameter	Arm A		Arm B		p value
	(Male)		(Female)
	(N = 229)		(N = 104)
	n	%	n	%
Age, years					0.0010^b
Mean (SD)	65 (8.8)		62 (10.4)
Median (Q1, Q3)	66 (60, 72)		61 (55, 69)
Range	36–84		37–85
Comorbidities					0.2809^b
Mean (SD)	3 (2.1)		3 (2.1)
Median (Q1, Q3)	2 (1, 4)		2 (1, 4)
Range	1–10		1–10
ECOG					0.1643^c
0	91	40	29	28
1	107	47	60	58
2	23	9	10	9
3	2	1	1	1
Missing	6	3	4	4
Smoking habits					< 0.0001^d
Smoker/ex-smoker	222	97	66	63
Non-smoker	7	3	38	37
Marital status					0.0002^c
Single	25	11	19	18
Married/Partnered	168	73	51	49
Widowed	9	4	13	13
Divorced	4	2	6	6
Missing	23	10	15	14
Educational level					0.0098^c
No education	25	11	9	9
Basic	118	52	37	35
Higher	31	13	26	25
Missing	55	24	32	31
Histology					0.0082^c
Adenocarcinoma	158	69	87	84
Squamous cell	44	19	8	8
Others	27	12	8	8
Mutations^a
EGFR+	11	5	21	20
ALK+	4	2	5	5
BRAF+	1	1	1	1

Italic values are statistically significant
^aEGFR mutation status was not determined in 67 men (29%) and 8 (8%) women; ALK mutation status was not determined in 103 men (45%) and 26 (25%) women; BRAF mutation status was not determined in 200 men (87%) and 93 (90%) women
^bWilcoxon signed-rank test
^cFisher’s exact test
^dChi-squared test

ISSN: 2050-7283